Common questions about Sibilla Plus (FAQ)
Q: How quickly does Sibilla Plus start to be effective?
A: According to official prescribing information, contraceptive protection is typically considered established immediately if the first active tablet is taken on Day 1 of your menstrual cycle. If the start is between Days 2 and 5, regulatory guidance advises using a temporary non-hormonal barrier method for the first seven days of the cycle.
Q: What should I expect in the first month of taking Sibilla Plus?
A: Regulatory documents indicate that women may experience irregular bleeding, often called spotting or breakthrough bleeding, which is often observed to be more frequent during the initial months of use. Official safety information also notes that the risk of developing a blood clot (VTE/ATE), while rare, is highest during the first year of use, especially when first starting or re-initiating the pill.
Q: Are there specific foods or drinks that I should avoid while on Sibilla Plus?
A: The official product information mentions that grapefruit juice may increase the plasma concentration of the pill's hormonal components in the body. For this reason, official guidance suggests limiting or avoiding it.
Q: What types of antibiotics are known to reduce the effectiveness of Sibilla Plus?
A: Some powerful antibiotics, such as Rifampicin, are documented as substances that can increase the speed at which the body processes hormones, which may reduce the pill's effectiveness. For many other antibiotics, if an interaction is suspected, regulatory guidance describes using a temporary non-hormonal barrier method during treatment and for the following seven days.
Q: Is it okay to use herbal supplements while taking Sibilla Plus?
A: Regulatory documents specifically state that the herbal medicine St. John's wort can interfere with how the body metabolizes the hormones in the pill. Using it alongside Sibilla Plus can compromise the medication's effectiveness, and it is advised against its use.
Q: Is Sibilla Plus considered safe to use for women over 35?
A: The official contraindications strictly prohibit the use of this pill for women over the age of 35 who smoke. The restriction is associated with a significantly increased risk of serious cardiovascular events documented in safety records.
Q: Do I need to take a break from Sibilla Plus after a certain number of years?
A: The established regimen for this medicine is designed for continuous, long-term use as needed. However, official safety information indicates that the risk of serious blood clots (thromboembolic events) is highest upon re-initiation after a break of four weeks or longer.
Q: What is the purpose of the placebo pills in the Sibilla Plus pack?
A: The seven inactive (placebo) tablets are included primarily to maintain a daily routine of taking a pill. This structured approach helps ensure continuous adherence to the daily schedule of the active tablets when the next cycle begins.
Q: Why might a doctor prescribe Sibilla Plus instead of a progestogen-only pill?
A: Sibilla Plus is a combined pill containing both an estrogen and a progestogen with anti-androgenic properties. The official documentation describes its use for both contraception and treatment for moderate acne, a benefit not typically noted for progestogen-only pills.
Q: How long does it take for side effects from Sibilla Plus to typically go away?
A: For common side effects like irregular uterine bleeding (spotting), regulatory documentation notes that this is often more frequent during the first few months of use and often improves thereafter, according to safety reports. The duration for other common side effects can vary among individuals.
Q: What are the signs of a serious, but rare, side effect mentioned in official documents?
A: Serious, rare side effects include thromboembolic events (blood clots). Signs of a Deep Vein Thrombosis (DVT) may involve pain, swelling, or warmth in one leg. Signs of a Pulmonary Embolism (PE) may include sudden shortness of breath or sharp chest pain. Official safety documents indicate that these symptoms require immediate medical attention.
Q: What should I do if I miss a pill of Sibilla Plus?
A: Official product information outlines steps for missed active tablets based on the delay. If the delay is less than 24 hours, taking the tablet immediately is advised, and protection is generally considered to maintain contraceptive protection. If the delay is more than 24 hours, official guidance advises taking the missed tablet, continuing the pack, and using additional barrier contraception for seven days.
Q: Is the active ingredient in Sibilla Plus the same as in other common pills?
A: Sibilla Plus contains Ethinylestradiol, which is a synthetic estrogen widely used in combined oral contraceptives. Its progestogen component, Dienogest, provides specific anti-androgenic properties that distinguish it from some other commonly prescribed hormonal pills.
Q: Does Sibilla Plus interact with common over-the-counter pain relievers?
A: The official product information does not specifically list interactions with common over-the-counter pain relievers. However, since all medication use can vary, it is necessary to consult with a healthcare professional regarding all concurrent medicines.
Q: Does Sibilla Plus affect cholesterol levels?
A: Regulatory documents note that severe dyslipoproteinaemia (a serious lipid metabolism disorder) is a contraindication. Hormone levels can affect lipid and glucose metabolism, and official documents indicate that monitoring may be required for certain patients.
Q: Does Sibilla Plus interact with common antifungal treatments?
A: Antifungal agents, particularly those known as Azole antifungals, may increase the concentration of the hormonal components in the body. Official regulatory guidance advises that any concurrent use of these medicines typically requires monitoring by a healthcare professional.
Q: What is the guidance on using Sibilla Plus if I have diabetes?
A: Official prescribing information states that Sibilla Plus is contraindicated in patients with diabetes that has developed vascular complications. For diabetic patients without vascular complications, regulatory guidance requires careful medical monitoring while using the pill.
Q: Is there a link between Sibilla Plus and changes in vision?
A: Regulatory adverse event listings include visual disturbances, such as blurred vision or sudden partial or complete loss of vision, as a rare and serious symptom. The occurrence of such a symptom requires immediate discontinuation of the pill and emergency medical attention.
Q: How is the use of Sibilla Plus monitored by doctors?
A: Official guidelines recommend a complete medical history and physical examination, including a blood pressure check, before beginning the pill. Regular check-ups are also generally recommended throughout the course of use, especially for individuals with existing risk factors.
Q: Is it safe to drink alcohol while taking Sibilla Plus?
A: The official product information does not list alcohol as a contraindication or an interaction that reduces contraceptive effectiveness. The document lists no specific constraints regarding alcohol use.
Q: Can women with a history of gallbladder problems use Sibilla Plus?
A: The estrogen component in the pill may increase the formation of gallstones. Conditions such as cholecystitis (gallbladder inflammation) or pre-existing gallstones are listed as conditions that typically require careful monitoring and medical review before the pill is used.
Q: Can I use Sibilla Plus if I am taking medicines for HIV?
A: Some medicines used to treat HIV, such as specific antiretrovirals, can significantly decrease the concentration of the pill's estrogen component. This may result in a reduction of contraceptive protection, and supplementary barrier contraception may be required according to medical guidance.
Q: Is it possible for Sibilla Plus to cause skin darkening (melasma)?
A: Official warnings note a risk of chloasma, which appears as patches of brown skin discoloration on the face, particularly in women with a history of the condition during pregnancy. Official guidance suggests avoiding prolonged exposure to the sun or ultraviolet radiation while taking the pill.
